Related Experiment Video
Updated: Jul 15, 2026
08:40
Rat Burn Model to Study Full-Thickness Cutaneous Thermal Burn and Infection
Published on: August 23, 2022
Vancomycin population pharmacokinetics in patients with burns
Yan Shi1, Yijin Yao2, Xiaoshuang He3
1Department of Burn, Shanghai Burn Institute, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Frontiers in Medicine
|July 13, 2026
Summary
A new population pharmacokinetic model for vancomycin in burn patients shows increased drug clearance correlated with creatinine clearance. This model aids in optimizing vancomycin dosing for severe infections in this population.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Infectious Diseases
Background:
- Vancomycin is crucial for treating severe infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
- Existing pharmacokinetic studies in burn patients lack a robust population model using routine therapeutic drug monitoring data.
- A significant gap exists in understanding vancomycin pharmacokinetics in adult burn patients.
Purpose of the Study:
- To develop a population pharmacokinetic (PopPK) model for vancomycin in adult burn patients.
- To evaluate the predictive performance of the developed PopPK model.
- To establish a basis for individualized vancomycin dosing in burn patients.
Main Methods:
- Non-linear mixed-effects modeling was used to analyze vancomycin serum concentrations from 93 burn patients.
- Covariates such as creatinine clearance (CrCL), BMI, and burn area were assessed for their impact on vancomycin PK.
- Model stability was confirmed via bootstrap analysis, and predictive accuracy was compared to Clincalc using external data.
Main Results:
- A one-compartment model effectively described vancomycin pharmacokinetics in burn patients.
- Creatinine clearance (CrCL) was identified as a significant covariate influencing vancomycin clearance (CL).
- The developed model demonstrated superior predictive accuracy compared to existing tools like Clincalc.
Conclusions:
- Vancomycin clearance is elevated in burn patients and significantly correlates with CrCL.
- The developed PopPK model offers a reliable framework for tailoring vancomycin dosage in adult burn patients.
- This research supports optimized vancomycin therapy for MRSA infections in burn survivors.
Related Concept Videos
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:20Estimation of k and VD of Aminoglycosides
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
01:22Burn Injuries
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...